Kimberly-Clark Forms Strategic Partnership With Suzano To Create JV Company

Kimberly-Clark (KMB) and Suzano S.A. (SUZ) have agreed to form a strategic partnership, creating a new international tissue and professional products company where Suzano will own 51% and Kimberly-Clark 49%; Kimberly-Clark will contribute its International Family Care and Professional (IFP) business, which generated $3.3 billion in net sales in 2024, and license its global brands to the venture. The deal, expected to close in mid-2026, is projected to increase Kimberly-Clark's adjusted earnings per share by $0.30 to $0.40 in the first full year and allows Kimberly-Clark to focus on higher-growth segments while reducing exposure to volatile input costs.

Analysis

Kimberly-Clark Corp. (KMB) is strategically repositioning its portfolio by entering into a partnership with Brazil's Suzano S.A. (SUZ) to form a new international tissue and professional products company. Kimberly-Clark will hold a 49% interest in this venture, contributing substantially all assets of its International Family Care and Professional (IFP) business, which generated approximately $3.3 billion in net sales in 2024. This transaction is designed to allow Kimberly-Clark to concentrate on its higher-growth, higher-margin International Personal Care and North America Tissue and Professional businesses, while simultaneously reducing its exposure to volatile input costs, thereby aiming for more predictable and consistent margins and profit growth. The deal, reflecting a moderately positive sentiment (overall score 0.65, KMB-specific score 0.75), is expected to be accretive to Kimberly-Clark's adjusted earnings per share by $0.30 to $0.40 in the first full year following its anticipated mid-2026 close. Kimberly-Clark will license its five global brands, including Scott and Kleenex, to the new entity, and will classify the contributed IFP businesses as discontinued operations starting with its second-quarter earnings results. Suzano will own 51% of the venture and will have an option to purchase Kimberly-Clark's remaining 49% ownership interest under an agreed valuation framework. The transaction has received unanimous approval from Kimberly-Clark's Board of Directors and is subject to customary closing conditions and regulatory approvals.

Key Decisions for Investors

• Investors should consider the strategic rationale behind Kimberly-Clark's partnership, which aims to enhance focus on higher-margin segments and improve earnings predictability through reduced exposure to input cost volatility, supported by an anticipated $0.30 to $0.40 adjusted EPS accretion.
• Monitor the progress of the transaction towards its mid-2026 closing, including regulatory approvals, as the realization of financial benefits is contingent upon successful completion.
• Evaluate the long-term impact of Suzano's option to acquire Kimberly-Clark's remaining 49% stake, which presents a potential future divestiture and liquidity event for this part of the business.